PUBLISHER: Lucintel | PRODUCT CODE: 1263910
PUBLISHER: Lucintel | PRODUCT CODE: 1263910
Recombinant Protein Market Trends and Forecast
The future of the recombinant protein market looks promising with opportunities in pharma & biotechnology companies, academic & research institutes, and diagnostic laboratories. The global recombinant protein market is expected to reach an estimated $3.8 billion by 2028 with a CAGR of 11.5% from 2023 to 2028. The major drivers for this market are increasing cases of chronic diseases and rise in research and development expenditure on biologics drugs.
Recombinant Protein Market by Product Type, Expression System, Application, End Use Industry, and Region
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Recombinant Protein Market by Segments
Recombinant Protein Market by Segment
Recombinant Protein Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2028]:
Antibodies
Antigens
Enzymes
Hormones
Others
Recombinant Protein Market by Expression System [Value ($B) Shipment Analysis from 2017 to 2028]:
Microbes
Plants
Animals
Recombinant Protein Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Drug Discovery and Development
Research Application
Therapeutic Use
Diagnostics
Others
Recombinant Protein Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
Biotechnology and Pharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Others
Recombinant Protein Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
List of Recombinant Protein Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, recombinant protein companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the recombinant protein companies profiled in this report include-
Abcam
Sino Biological
R&D Systems
GenScript
Bio-Rad Laboratories
Recombinant Protein Market Insights
Lucintel forecasts that antibodies will remain the largest product type segment over the forecast period due to the growing cases of diabetes across the globe.
Pharma & biotechnology companies are expected to remain the largest end use industry segment due to the increasing the demand for recombinant proteins in drug research for prediction, prognosis, and diagnosis.
North America will remain the largest region due to increasing expenditure on research and development and growing number of clinical trials in the region.
Features of the Recombinant Protein Market
Market Size Estimates: Recombinant protein market size estimation in terms of value ($B)
Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
Segmentation Analysis: Recombinant protein market size by various segments, such as product type, expression system, application, end use industry, and region
Regional Analysis: Recombinant protein market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth Opportunities: Analysis on growth opportunities in different product types, expression systems, applications, end use industries, and regions for the recombinant protein market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the recombinant protein market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the recombinant protein market size?
Answer: The global recombinant protein market is expected to reach an estimated $3.8 billion by 2028.
Q2. What is the growth forecast for recombinant protein market?
Answer: The global recombinant protein market is expected to grow with a CAGR of 11.5% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the recombinant protein market?
Answer: The major drivers for this market are increasing cases of chronic diseases and rise in research and development expenditure on biologics drugs.
Q4. What are the major segments for recombinant protein market?
Answer: The future of the recombinant protein market looks promising with opportunities in pharma & biotechnology companies, academic & research institutes, and diagnostic laboratories.
Q5. Who are the key recombinant protein companies?
Answer: Some of the key recombinant protein companies are as follows:
Abcam
Sino Biological
R&D Systems
GenScript
Bio-Rad Laboratories
Q6. Which recombinant protein segment will be the largest in future?
Answer: Lucintel forecasts that antibodies will remain the largest product type segment over the forecast period due to the growing cases of diabetes across the globe.
Q7. In recombinant protein market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increasing expenditure on research and development and growing number of clinical trials in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.